Cognitive Testing on Mobile & Wearable Devices

Similar documents
Adaptive Design in CIAS

Schizophrenia Battery

Cognitive Health in the Workplace

CANTAB Test descriptions by function

INTRODUCTION TO THE REMOTE ASSESSMENT OF DISEASE AND RELAPSE (RADAR) PROGRAMME

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER

European Prevention of Alzheimer s Dementia (EPAD)

Digital Biomarkers in Neurology. Digital Biomarkers Conference March 31, 2016

NEUROPSYCHOLOGICAL ASSESSMENT S A R A H R A S K I N, P H D, A B P P S A R A H B U L L A R D, P H D, A B P P

Collaborating to Develop Digital Biomarkers with Passive Data Collection

Regulatory Challenges across Dementia Subtypes European View

An Introduction to the CBS Health Cognitive Assessment

Biological Risk Factors

Neuropsychology and Parkinson s Disease. Erin Holker, Ph.D., ABPP Neuropsychology Laboratory

Wearable Devices and Smoking Cessation: What Have We Learned About Using Wearables in Behavior Change Research? Susan Murphy

Outcome measures in neuroscience clinical trials

Translational Clinical Science

THE ICA INTEGRATED COGNITIVE ASSESSMENT TACKLING DEMENTIA WHEN IT COUNTS

Movement and Memory. Undergraduate degree. Technology & Movement: New Approaches to Understanding Change. Graduate degree

PS3021, PS3022, PS4040

ADHD in children and adolescents: examination of the association of neurological subtle signs with working memory problems

CYGNUS: A digital brain health platform for improving dementia outcomes

CTIS-Adverse Effects

ERP Feature of Vigilance. Zhendong Mu

Early intervention in Bipolar Disorder

The future of diabetes clinical trials

La cognizione sociale

presents Approach to Dementia Care

Augmented Cognition to enhance human sensory awareness, cognitive functioning and psychic functioning: a research proposal in two phases

Neuropsychology of Attention Deficit Hyperactivity Disorder (ADHD)

Neuropsychological Evaluation of

Mentis Cura November

Conscious control of movements: increase of temporal precision in voluntarily delayed actions

Beyond the Psychologist s Report. Nancy Foster, PhD Institute for Brain-Behavior Integration

Human Factors & User Experience LAB

Service Related Project. Kimberley Keegan

TestMyBrain Consulting for RDoC Field Test Battery

MSc Neuroimaging for Clinical & Cognitive Neuroscience

Comparing MCI Patients to Healthy Controls using Three ERP Paradigms

Changes, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS

APPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA

What Medicine can Learn from Marketing

Towards scientific validated digital biomarkers measured by patient's own smart devices: cases studies from Parkinson's disease and Multiple Sclerosis

Challenges in Developing Learning Algorithms to Personalize mhealth Treatments

Complexity Made Simple

Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI

Cognizanti. You Don t Join Us; We Join You. Insurance/Health & Wellness VOLUME

Web Usability Testing With Concurrent fnirs and Eye Tracking

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME

GLUCOMETER: High Level Design

NEUROPSYCHOMETRIC TESTS

Communication Access Features on Apple devices

Clinical Trial Glossary

Addressing Gaps in MS Care. November 6, :00 AM - Noon

The Neuropsychological Impairment Scale (NIS) Self-Report Form

Electronic Care Centre for Caregivers of Patients with Alzheimer's disease

The Brain is Still a Mystery. National Institutes of Health 7/11/2012

Alzheimer s disease dementia: a neuropsychological approach

Why ICT are interesting for Frailty

The value of the CANTAB battery in evaluating

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

IQ Tests, IQ Augmenting Technologies & How To Join Mensa

sensors ISSN

NEUROCOGNITIVE, OUTCOMES IN PKU: IT S TIME TO RAISE THE BAR

Running head: MOOD AND COGNITION IN EVERYDAY LIFE 1. Mood Effects on Memory and Executive Control in a Real-Life Situation

2.0 Synopsis. Levodopa-Carbidopa Intestinal Gel M Clinical Study Report R&D/15/1285. (For National Authority Use Only)

Using the Person-based Approach. cognitive decline. Dr Alex Milton, Psychology

So, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International

Effects of simultaneously performed cognitive and physical training in older adults

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University

Why Cognition Matters: Impact of Cognitive Impairment on Safety and Independent Living Skills

Fundamentals of Cognitive Psychology, 3e by Ronald T. Kellogg Chapter 2. Multiple Choice

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Evoked Response Potential Latency Modeling and Production Time Prediction

Capacity and Older Adults. Kenneth I. Shulman

Table 1: Summary of measures of cognitive fatigability operationalised in existing research.

The Neuropsychology of

Recognizing and Managing the Emotional Aspects of Parkinson s. Pamela R. Palmentera, LCSW Coordinator & Clinical Social Worker

Effect of real-time monitoring and notification

CNADC NIA ADC Clinical Task Force UDS Neuropsychology Work Group April 2011

Discovering Breakthrough Treatments for Human Disease. Discovering Breakthrough Treatments for Human Disease

WP 7: Emotion in Cognition and Action

Beyond AI: Bringing Emotional Intelligence to the Digital

FINAL PROGRESS REPORT

Wearable Devices for Heart Disease, Sleep Apnea, and Health. Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System

Technology Innovation Alert. N o n - i n v a s i v e D i a b e t e s M o n i t o r i n g. 16 December 31 December, Published. Granted.

The evox System. A medical device to measure and train the brain evox System

Revealing The Brain s Hidden Potential: Cognitive Training & Neurocognitive Plasticity. Introduction

UNLOCKING THE MYSTERIES OF THE BRAIN

NeuroTracker Published Studies & Research

iage: PERSONALIZED TECHNOLOGIES FOR FACILITATING HEALTH, WELLNESS AND SUCCESSFUL AGING

Practical Application using Behavior-Based Ergonomics Therapy (BBET) Program

Cancer and Cognitive Functioning: Strategies for Improvement

Alzheimer s Disease Research

Where No Interface Has Gone Before: What Can the Phaser Teach Us About Label Usage in HCI?

KNOWLEDGE VALORIZATION

Regional Grey Matter Atrophy is associated with Social Cognition impairment in Progressive Multiple Sclerosis (MS).

Assessing cognitive function after stroke. Glyn Humphreys

Neuro Q no.2 = Neuro Quotient

Transcription:

Cognitive Testing on Mobile & Wearable Devices Krystyna Zaluski CANTAB Connect Prodromal Alzheimer s Background Cambridge Cognition 2016. All rights reserved Page 1

Overview A neuroscience digital health company - Measuring cognition accurately Validated by over 30 years of neuroscience research A measure of cognitive function in over 100 indications Trusted by the world s top pharmaceutical companies

Technology Platforms for Cognitive Testing Research tools Tools for clinical and research trials to detect effects of drugs and environmental changes At-home testing Cognitive tests that can be completed by participants at home High Frequency testing Frequent monitoring of cognitive ability using wearable devices In-clinic tools Cognitive assessments for clinical use that can identify those who require further investigation Neuroanalytics Consultancy We provide expertise in the design, analysis and interpretation of neuropsychological endpoints in cognitive studies and clinical trials with extensive experience using research and analytic approaches.

Overview CANTAB C O G N I T I V E S C I E N C E CANTAB has been used to assess over 250,000 Participants worldwide

Specific to Cognitive Domain

Specific to Neural Mechanisms Digital Biomarker Reaction Time Rapid Visual Information Processing Spatial Working Memory Episodic Memory

Worse performance score Sensitive to Disease State Cognitive Signature 4 3 2 diagnosis AD MCI PD 1 0 AT_cat EF_cat EM_cat PS_cat WM_cat Attention Executive Function Episodic domain Memory Processing speed Working Memory

Cognition is subject to daily fluctuations

How to measure Cognition in the real world

Daily assessment across platforms and devices software enables an individual to complete an assessment on a range of mobile and wearable devices without having to visit a clinic or be helped by a health care professional. Drawing tasks to measure memory and executive function. Emotional recognition tasks to measure social cognition. N-back tasks to measure memory and attention.

Best Practice Approach Decisions are made with the individual in mind Patient Experience Cog Test Validity Cognitive test selection and adaptation designed with scientific rigor Large Data Sets of objective cognitive measurement and passive data points Meaningful Data

Validation Process Page 12

Developing a cognitive test for high-frequency testing N-back task activates a network of areas in the brain including frontal and parietal regions (Owen et al., 2005). There is significant variation across and within days on n-back performance, partly linked to mood and motivation (Brose et al., 2012). Rose & Ebmeier. Journal of affective disorders 90 (2006): 149-161. Owen et al., Human brain mapping 25 (2005): 46-59. Brose, Schmiedek, Lövdén & Lindenberger. Emotion 12 (2012): 605.

Phase 1: Proof of concept study in healthy volunteers Study design: 10 (4 females) aged 25-55 Sensor data (heart rate, skin temperature, GSR) measured continuously between 0900-1900 4 CANTAB tasks (SWM, RVP, AST, ERT) and the PANAS administered each day after 1700 Cognitive & mood assessment scheduled hourly Presentation = 600 ms ISI = 600 ms 2-back match Cormack et al, AAIC 2016

Baseline performance AST.correct RVPA RVP.False.Alarm age SWM.Errors linear intercept Phase 1: Detailed cognitive data 1-minute micro-tests capture meaningful across-time variation and correlate with gold-standard computerised tests. Revealed issues with device and dynamic range of the test. intercept 1 r= 0.52 linear 0.82 1 0.9 age 0.52 0.35 1 SWM.Errors v 0.28 0.32 0.32 1 0.8 RVPA 0.19 0.04 0.09 0.19 1 RVP.False. Alarm 0.36 0.65 0.08 0.33 0.39 1 30 40 50 age AST.correct 0.34 0.28 0.48 0.45 0.40 0.25 1 1 0 1 Cormack et al, AAIC 2016

Phase 2: Design refinement using web-based testing Findings from phase 1: A number of participants rapidly reached ceiling People were giving symbols names verbal recording of the stimuli, and familiarity with symbols over time Issues with the device used in the proof-of-concept: battery life, limited display, discontinuation Questions for phase 2: Change of symbol design and larger bank of symbols to reduce availability of verbal strategies Could we titrate the difficulty level without increasing the n: role of symbol complexity, timing parameters, and number of symbols Decision to use Apple iwatch

Phase 2: Participant Experience Refining task to increase dynamic range Converted task for web-based testing with redesigned stimuli Crowd-sourced A-B testing using Amazon m-turk Series of experiments exploring the impact of task parameters on participant performance using: Presentation time Symbol design Number of unique symbols n = 994 participants aged 20 64 in total n = 88 also completed CANTAB Spatial Working memory test and CANTAB PAL (episodic memory)

Phase 2: Cognitive Test Validity Iterative A-B experimentation determined: Significant effect of stimulus presentation time on performance Significant impact of number of symbols in trial Symbol design (e.g. number of segments + arrangement) did not significantly impact performance r=-0.41 P<0.001 Correlations with CANTAB test significant association with SWM, but not PAL. r=-0.10 P=0.37 Confirms sensitivity to working memory performance.

Phase 3: In-person testing and iterative design Would the same parameters work on the watch? How would participants perform over an extended time? Is the paradigm and testing schedule tolerable? What are some of the barriers to compliance? How can we make sure that patients understand the app and the tasks? N=7 subjects over 3 weeks. Apple watch N-back testing x3 times a day

Cognitive Testing on Mobile & Wearable Devices Krystyna.Zaluski@camcog.com CANTAB Connect Prodromal Alzheimer s Background Cambridge Cognition 2016. All rights reserved Page 20